In a subset of AML patients, eIF4E is substantially elevated and forms abnormally large nuclear bodies relative to early progenitor CD34+ cells or bone marrow mononuclear cells from healthy volunteers [145,146,147,148]. Here, EIF4E is linked to acute myeloid leukemia.